I.V.F. patients are faced with a growing list of costly “add-ons.” For one such test, some say more robust research is needed to support its effectiveness.
from NYT > Health https://ift.tt/3soQzii
December 18, 2021
Rose
Health - The New York Times, NYT > Health
No comments
Related Posts:
Weekly Health Quiz: Coffee, Dorm Rooms and ExerciseTest your knowledge of this week’s health news. from NYT > Health https://ift.tt/3z7m7t7 … Read More
Breaking Down the ‘Wellness-Industrial Complex,’ an Episode at a TimeThe “Maintenance Phase” podcast interrogates the science behind health food trends, fad diets and popular nutritional advice. from NYT > Health https://ift.tt/3EcQ0Mn … Read More
Otro riesgo de la covid: problemas persistentes en los riñonesEn un gran estudio reciente, los pacientes recuperados de COVID-19 tuvieron 35 por ciento más probabilidades de sufrir daños a largo plazo en los riñones o un deterioro de la función renal. from NYT > Health https://ift.t… Read More
Ann Patchett on Taking a Bad Fall to Find Good LuckAnn Patchett finds that misfortune in small doses can cast a glittering light on the rest of life. from NYT > Health https://ift.tt/2X6ymZz … Read More
Fauci Says U.S. Virus Cases Are More Than Ten Times Too High“The endgame is to suppress the virus,” Dr. Anthony S. Fauci told Axios. “Right now, we’re still in pandemic mode.” from NYT > Health https://ift.tt/3E2YfdG … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment